time-dependent, and the relevant time frame may span several decades, over which adequate historical exposure records are unlikely to exist.
Second, associations between an estimated exposure and the occurrence of disease can result not only from an underlying causal relationship, but as a result of systematic error or study bias. For example, in an occupational study disease risk might correlate with cumulative exposure, which in turn might simply indicate longer-term workers who by definition would be older and in whom cancer risk could be considerably higher. Cumulative exposure might also be a surrogate for other substances especially likely to be present in earlier years of a production facility, or reflect the ability to follow long-term employees longer (versus those lost to follow-up) thereby providing a greater opportunity to detect the occurrence of the disease of interest. More subtly, due to the lack of complete exposure information, historical estimates may be incorrectly extrapolated back in time. If, due to the general impression that early production years conferred much higher exposure, exposures are over-estimated for early years of employment, a spurious inverse dose-response may be observed. Depending on the direction and degree of all study biases, an observed dose-response may not at all reflect the true underlying doseresponse relationship.
Even in the absence of systematic error, epidemiological studies often suffer from low statistical power due to limited numbers of observed events (usually disease occurrences), especially for rare diseases such as specific cancers, even if the study population is large. At the lowest estimated doses, where risks are anticipated to be low as well, the small number of observed cases may even preclude the differentiating of no increase in risk from a linear dose-response or a threshold (or other more complicated) dose-response function.
Assuming that sample sizes are large enough to assure reasonable statistical power, exposure can be estimated reasonably validly, and that a true dose-response relationship is present, several additional statistical/ analytical challenges remain. The three papers that follow address different (but related) statistical or analytical aspects of characterizing doseresponse relationships in observational studies.
In the first paper of this section, Dr. Crump discusses the impact that random error in the exposure measurement can have on the assessment of the shape of the dose-response (Crump 2005) . As is the case in many epidemiological studies, the exposure estimates are based on incomplete data, and generally assumed to have no random error, raising the possibility that the risk function that is derived is erroneous. This also, as the paper addresses, can have serious implications for risk extrapolation.
In the second paper, Dr. van Wijngaarden proposes a novel graphical approach for uncovering dose-responses and elucidating possible nonlinearity of exposure-response in epidemiological studies using standard-ized morbidity or mortality ratio (SMR) analyses (van Wijngaarden 2005) . SMR analyses remain popular in study settings where the available "exposed" population (often defined as an occupational or community cohort) is finite, and only used to determine the actual number of cases of the outcome of interest ("observed"): and to enumerate the persontime at risk of the cohort so that external, statistically stable, reference rates may be used to derive the "expected" number of outcomes. The proposed method is especially attractive in that it allows for moving (timedependent) windows of exposure.
In the third paper, Drs. May and Bigelow discuss practical statistical modeling approaches for identifying and characterizing non-linear doseresponse relationships using epidemiological data (May and Bigelow 2005) . They review various factors that may influence or even interfere with the analyst's ability to properly discover and characterize the underlying dose-response function. With a focus on threshold and J-shaped relationships, they deftly illustrate the actual impact these factors have on several statistical methods commonly used to characterize dose-response relationships.
Combined, these papers underscore the challenges epidemiologists and statisticians analyzing observational epidemiological data face in deriving valid and defensible conclusions regarding not only the presence, but also the shape, of the underlying dose-response relationship. Better quantitative characterization of these relationships will be useful beyond causal inference, by impacting practical decision-making and supporting toxicological and biological discovery. Further refinement of available statistical approaches, as well as development of new strategies, are clearly needed.
